4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-25-321142
Chief Scientific Officer sold 8,500 shares at an average $30.02 ($255,130)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/ownership.xml…